Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T06:53:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T08:51:06.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual content with an access-restricted notice. The additions include the 403 text and typical site header/footer indicating the page is blocked.
    Difference
    22%
    Check dated 2026-09-20T03:50:37.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the page, indicating a new revision of the study record metadata.
    Difference
    0.0%
    Check dated 2026-08-29T23:38:55.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now displays a server error (500) with an 'An error occurred' message, indicating the requested study page is currently unavailable. As a result, no study details are accessible at this time.
    Difference
    21%
    Check dated 2026-08-08T18:52:26.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a minor platform update. No study content changes are reflected in this update.
    Difference
    0.0%
    Check dated 2026-07-25T10:37:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.